GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microlin Bio Inc (GREY:MICB) » Definitions » Accounts Payable

Microlin Bio (Microlin Bio) Accounts Payable : $0.01 Mil (As of Sep. 2015)


View and export this data going back to 2014. Start your Free Trial

What is Microlin Bio Accounts Payable?

Microlin Bio's Accounts Payable for the quarter that ended in Sep. 2015 was $0.01 Mil.

Microlin Bio's quarterly Accounts Payable declined from Mar. 2015 ($0.00 Mil) to Jun. 2015 ($0.00 Mil) but then increased from Jun. 2015 ($0.00 Mil) to Sep. 2015 ($0.01 Mil).


Microlin Bio Accounts Payable Historical Data

The historical data trend for Microlin Bio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microlin Bio Accounts Payable Chart

Microlin Bio Annual Data
Trend Dec12 Dec13 Dec14
Accounts Payable
- - -

Microlin Bio Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.01

Microlin Bio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Microlin Bio Accounts Payable Related Terms

Thank you for viewing the detailed overview of Microlin Bio's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Microlin Bio (Microlin Bio) Business Description

Traded in Other Exchanges
N/A
Address
MicroLin Bio Inc is engaged in the healthcare sector. It is a therapeutic and diagnostic company focusing on microRNA and its role in oncology. MicroRNAs represent a class of diagnostics and therapeutics that are more effective in the diagnosis and treatment of cancer, with the potential for mitigating side effects in comparison with conventional small molecule drugs or biologics. The company's properties include molecular diagnostics and companion tests, cancer therapeutics, and delivery platform technology. Molecular diagnostics & companion tests include tests such as Lumira, Omira, Colomira, and Promira. Cancer therapeutics includes lumiralin, omiralin, colomiralin, and promirali.

Microlin Bio (Microlin Bio) Headlines

No Headlines